Skip to main content

Table 2 Group (SMA vs DLPFC rTMS) charactristics

From: Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study

Variable

Category

n

rTMS protocol

p-value

95%CI

SMA rTMS

DLPFC rTMS

lower

upper

SMA

DLPFC

SMA

DLPFC

Sample size (n)

 

65

38

27

     

Comorbidity (n)

 

34

20

14

0.09

    

On medication (n)

 

51

21

30

0.77

    

rTMS reponse

Yes

30

21

9

0.12

    

No

35

17

18

     

Age

Mean (SD)

32.25 (10.23)

31.58 (10.64)

33.19 (9.75)

0.54

27.03

39.49

33.00

44.38

Gender

Male

30

17

13

0.80

    

Female

35

21

14

     

Education

Diploma or lower

24

14

10

0.89

    

Associate degree

7

4

3

     

Bachelor degree

22

13

9

     

Masters degree

6

3

3

     

Not reported

6

4

2

     

Marital status

Single

26

15

11

0.94

    

Married

33

20

13

     

Divorced or separated

6

3

3

     

BL Y-BOCS

Mean (SD)

22.75 (6.66)

23.52 (7.37)

21.66 (5.44)

0.27

18.74

26.52

17.07

23.88

BL BAI

Mean (SD)

25.90 (11.01)

24.71 (10.15)

27.59 (12.10)

0.32

20.19

30.74

20.47

33.83

BL BDI-II

Mean (SD)

22.64 (8.95)

21.84 (9.86)

23.77 (7.54)

0.39

18.36

27.07

21.70

29.98

  1. Note: SMA Supplementary motor area, rTMS repetitive transcranial magnetic stimulation, DLPFC dorsolateral prefrontal cortex, SD Standard Deviation, Y-BOCS Yale-Brown Obsessive-Compulsive Scale, BAI Beck Anxiety Inventory, BDI-II Beck Depression Inventory; Group differences based on the applied protocol (SMA vs DLPFC rTMS) in demographic variables were explored using chi-square analysis or Fisher’s exact test for categorical variables and t-tests for continuous variables